Market revenue in 2023 | USD 113.3 million |
Market revenue in 2030 | USD 220.6 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Tethered pumps |
Fastest growing segment | Patch Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Patch Pumps, Tethered Pumps |
Key market players worldwide | Medtronic PLC, Roche Holding AG ADR, Tandem Diabetes Care Inc, Insulet Corp, Ypsomed Holding AG, Zealand Pharma A/S, CellNovo, SOOIL Developments |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin pump market will help companies and investors design strategic landscapes.
Tethered pumps was the largest segment with a revenue share of 77.32% in 2023. Horizon Databook has segmented the Australia insulin pump market based on patch pumps, tethered pumps covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia insulin pump market , including forecasts for subscribers. This country databook contains high-level insights into Australia insulin pump market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account